INPLASY2023100069

Risk of Eczema Herpeticum in atopic dermatitis patients receiving JAK inhibitors, biologics or other systemic therapy

Keywords: Eczema herpeticum, herpes simplex, atopic dermatitis, JAK inhibitors, cyclosporine, Dupilumab.

Download PDF - 2023100069

Review Status: Ongoing